TY - JOUR
T1 - Methods in capillary electrophoresis coupled to mass spectrometry for the identification of clinical proteomic/peptidomic biomarkers in biofluids
AU - Stalmach, Angelique
AU - Husi, Holger
AU - Mosbahi, Khedidja
AU - Albalat, Amaya
AU - Mullen, William
AU - Mischak, Harald
N1 - Publisher Copyright:
© Springer Science+Business Media New York 2015.
PY - 2015
Y1 - 2015
N2 - Proteomic biomarkers hold the promise of enabling assessment of patients according to a pathological condition aiming at improvements in diagnosis, prognosis, in general clinical patient management. Capillary electrophoresis coupled to an electrospray ionization time-of-flight mass spectrometer (CE-MS) allows the detection of thousands of small proteins and peptides in various biofluids, in a single, reproducible and time-limited step, enabling the simultaneous comparison of multiple individual proteins and peptides in biomarker discovery, but also in clinical applications. The reliability of the CE-MS platform, together with the use of a validated approach for data processing and mining is, to date, the most advanced technique for biomarker discovery of clinical significance. In this chapter, we report on the materials, methods and protocols used for CE-MS-based clinical proteomics allowing the reproducible profiling of biofluids.
AB - Proteomic biomarkers hold the promise of enabling assessment of patients according to a pathological condition aiming at improvements in diagnosis, prognosis, in general clinical patient management. Capillary electrophoresis coupled to an electrospray ionization time-of-flight mass spectrometer (CE-MS) allows the detection of thousands of small proteins and peptides in various biofluids, in a single, reproducible and time-limited step, enabling the simultaneous comparison of multiple individual proteins and peptides in biomarker discovery, but also in clinical applications. The reliability of the CE-MS platform, together with the use of a validated approach for data processing and mining is, to date, the most advanced technique for biomarker discovery of clinical significance. In this chapter, we report on the materials, methods and protocols used for CE-MS-based clinical proteomics allowing the reproducible profiling of biofluids.
KW - Biomarker
KW - Bodyfluid
KW - Capillary electrophoresis
KW - Mass spectrometry
KW - Peptide
UR - http://www.scopus.com/inward/record.url?scp=84921811250&partnerID=8YFLogxK
U2 - 10.1007/978-1-4939-1872-0_11
DO - 10.1007/978-1-4939-1872-0_11
M3 - Article
C2 - 25384747
AN - SCOPUS:84921811250
SN - 1064-3745
VL - 1243
SP - 187
EP - 205
JO - Methods in Molecular Biology
JF - Methods in Molecular Biology
ER -